Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000338366 | SCV000335477 | uncertain significance | not provided | 2015-09-16 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000671505 | SCV000796488 | uncertain significance | Glycogen storage disease, type V | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001778878 | SCV002015177 | uncertain significance | not specified | 2021-10-04 | criteria provided, single submitter | clinical testing | Variant summary: PYGM c.1349C>T (p.Ser450Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3e-05 in 229718 control chromosomes (gnomAD and publication data). c.1349C>T has been reported in the literature in two individuals affected with McArdle disease, including one homozygote (Deschauer_2007). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Labcorp Genetics |
RCV000671505 | SCV002314254 | pathogenic | Glycogen storage disease, type V | 2024-03-16 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 450 of the PYGM protein (p.Ser450Leu). This variant is present in population databases (rs756251887, gnomAD 0.01%). This missense change has been observed in individual(s) with McArdle disease (PMID: 17404776). ClinVar contains an entry for this variant (Variation ID: 283418). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PYGM protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000671505 | SCV004207245 | likely pathogenic | Glycogen storage disease, type V | 2024-02-12 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000671505 | SCV005374447 | likely pathogenic | Glycogen storage disease, type V | 2024-09-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000671505 | SCV005684142 | likely pathogenic | Glycogen storage disease, type V | 2024-06-19 | criteria provided, single submitter | clinical testing |